None Small Cell Lung cancer
Conditions
Interventions
Experimental:Aiyu capsule
control group:Anduosen capsule
Sponsors
Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Diagnosed as NSCC by imaging and/or histopathology or cytology; 2. Aged between 18~80 years old, both gender; 3. performance status(KPS) score above 60 points; 4. the excepted survival time longer than 3 months; 5. No serious diseases of heart, liver, kidney, blood and other systems; 6. Volunteers, and signed the informed consent; 7. In accordance with the standards of syndrome differentiation on deficiency of Qi and Blood; 8. All cases accepted chemotherapy (international standard solution and doses) in 2 weeks, and appeared grade 1-2 bone marrow suppression.
Exclusion criteria
Exclusion criteria: 1. Complicated with other diseases causing leukopenia such as hypersplenism, Hyperthyroidism, adrenocortical insufficiency, connective tissue diseases, Infectious Diseases (virus hepatitis, tuberculosis infection); 2. pregnant women and lactating women; 3. mental disorders patients; 4. poor compliance history in previous treatment; 5. No Blood disease and bone marrow metastatic tumor involved.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood routine tests include WBC, RBC, Hb, NEUT, PLT; | — |
Countries
China
Contacts
Public ContactYingjie Jia
Outcome results
None listed